Literature DB >> 6777245

Analysis of the autosomal mutation abo and its interaction with the ribosomal DNA or Drosophila melanogaster: the role of X-chromosome heterochromatin.

B Yedvobnick, H M Krider, B I Levine.   

Abstract

The autosomal recessive, maternal-effect mutation abnormal oocyte (abo: 2-38) preferentially lowers the viability os XO progeny. The severity of the sex-ratio distortion is reduced by duplications of maternal or zygotic heterochromatin (SANDLER 1970, 1977; PARRY and SANDLER 1974). Utilizing X-chromosome inversions that contain modifications in the quantity and arrangement of the heterochromatic functions, Xhabo and cr+, wer have extended our investigations of abo's influence on XO male recovery and rDNA redundancy (KRIDER, YEDVOBNICK and LEVINE 1979).--XO males bearing In(1)SCS1LSC4R or In(1)Wm4LSC4R are recovered twice as frequently as X chromosomes containing a single Xh region, implying that these inversions possess a duplication of Xhabo. abo mutant females heterozygous for In(1)SCS1LSC4R and wild-type X chromosomes generate XO progeny that do not contain elevated rDNA redundancies. XO males containing In(1)Wm4 exhibit male recoveries and rDNA elevations similar to those of males bearing a wild-type X chromosome, when both derive from a common abo/abo mother. Reciprocal crosses baetween In(1)Wm4 and Canton-S males to attached-X abo females show significant, though reuduced, sex ratios in the absence of an rDNA effect. The observation that abo can elevate the rDNA redundancy of In(1)Wm4, a chromosome that does not compensate, suggests that abo and cr+ functions are not directly related.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777245      PMCID: PMC1214253     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  11 in total

1.  Fine structure and evolution of DNA in heterochromatin.

Authors:  W J Peacock; A R Lohe; W L Gerlach; P Dunsmuir; E S Dennis; R Appels
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1978

2.  A genetic locus having trans and contiguous cis functions that control the disproportionate replication of ribosomal RNA genes in Drosophila melanogaster.

Authors:  J D Procunier; K D Tartof
Journal:  Genetics       Date:  1978-01       Impact factor: 4.562

3.  Ribosomal DNA and its expression in Drosophila melanogaster during growth and development.

Authors:  J Mohan
Journal:  Mol Gen Genet       Date:  1976-08-19

4.  Biochemical evidence for position-effect suppression of ribosomal RNA synthesis in Drosophila melanogaster.

Authors:  L D Puckett; L A Snyder
Journal:  Exp Cell Res       Date:  1975-10-01       Impact factor: 3.905

5.  Evidence for a set of closely linked autosomal genes that interact with sex-chromosome heterochromatin in Drosophila melanogaster.

Authors:  L Sandler
Journal:  Genetics       Date:  1977-07       Impact factor: 4.562

6.  Suppression of transcription of the ribosomal RNA cistrons of Drosophila melanogaster in a structurally rearranged chromosome.

Authors:  C E Nix
Journal:  Biochem Genet       Date:  1973-09       Impact factor: 1.890

7.  The genetic identification of a heterochromatic segment on the X chromosome of Drosophila melanogaster.

Authors:  D M Parry; L Sandler
Journal:  Genetics       Date:  1974-07       Impact factor: 4.562

8.  Evidence for position-effect suppression of the ribosomal RNA cistrons in Drosophila melanogaster.

Authors:  W K Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

9.  Studies on the mutation abnormal oocyte and its interaction with the ribosomal DNA of Drosophila melanogaster.

Authors:  H M Krider; B I Levine
Journal:  Genetics       Date:  1975-11       Impact factor: 4.562

10.  Studies on nucleolar RNA synthesis in Drosophila melanogaster. II. The influence of conditions resulting in a bobbed phenotype on rate of synthesis and secondary constriction formation.

Authors:  H M Krider; W Plaut
Journal:  J Cell Sci       Date:  1972-11       Impact factor: 5.285

View more
  9 in total

1.  Complete reversion of the abo phenotype in D. melanogaster occurs only when the blood transposon is lost from region 32E.

Authors:  V Cavaliere; F Graziani; S Andone; A Manzi; C Malva
Journal:  Mol Gen Genet       Date:  1991-12

2.  Nucleolar dominance in polytene cells of Drosophila.

Authors:  S A Endow
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

3.  The abnormal oocyte phenotype is correlated with the presence of blood transposon in Drosophila melanogaster.

Authors:  G Lavorgna; C Malva; A Manzi; S Gigliotti; F Graziani
Journal:  Genetics       Date:  1989-11       Impact factor: 4.562

4.  The genetic factors altered in homozygous abo stocks of Drosophila melanogaster.

Authors:  W Sullivan; S Pimpinelli
Journal:  Genetics       Date:  1986-11       Impact factor: 4.562

5.  Selective replication of ribosomal DNA repeats after loss of the abnormal oocyte phenotype in Drosophila melanogaster.

Authors:  F Graziani; L Vicari; E Boncinelli; C Malva; A Manzi; C Mariani
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  Factors influencing disproportionate replication of the ribosomal RNA cistrons in Drosophila melanogaster.

Authors:  F L Dutton; H M Krider
Journal:  Genetics       Date:  1984-07       Impact factor: 4.562

7.  Nucleolar dominance and replicative dominance in Drosophila interspecific hybrids.

Authors:  C Goodrich-Young; H M Krider
Journal:  Genetics       Date:  1989-10       Impact factor: 4.562

8.  Rescue from the abnormal oocyte maternal-effect lethality by ABO heterochromatin in Drosophila melanogaster.

Authors:  J Tomkiel; S Pimpinelli; L Sandler
Journal:  Genetics       Date:  1991-07       Impact factor: 4.562

9.  Developmental genetical analysis and molecular cloning of the abnormal oocyte gene of Drosophila melanogaster.

Authors:  J Tomkiel; L Fanti; M Berloco; L Spinelli; J W Tamkun; B T Wakimoto; S Pimpinelli
Journal:  Genetics       Date:  1995-06       Impact factor: 4.562

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.